COVID 19: Management of Decompensated Cirrhosis and Liver Transplant Recipients
Russell Rosenblatt, Elizabeth C. Verna – 21 May 2020
The COVID‐19 Pandemic: An Epidemiologic, Public Health, and Clinical Brief
John W. Ward, Carlos del Rio – 21 May 2020
Introduction
21 May 2020
Potential Treatments for SARS‐CoV‐2 Infection
Sameer K. Berry, Robert J. Fontana – 21 May 2020
Telemedicine and Telehepatology During the COVID‐19 Pandemic
Oren K. Fix, Marina Serper – 21 May 2020
Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta‐Analysis
Steven Young, Raseen Tariq, John Provenza, Sanjaya K. Satapathy, Kamal Faisal, Abhijit Choudhry, Scott L. Friedman, Ashwani K. Singal – 21 May 2020 – Data on prevalence and profile of nonalcoholic fatty liver disease (NAFLD) among individuals who are lean (normal body mass index) is unclear. Published data from studies comparing lean with obese NAFLD or with healthy subjects on prevalence, comorbidities, liver chemistry and histology, and metabolic/inflammatory markers were analyzed.
SARS‐CoV‐2 and the Liver: Considerations in Hepatitis B and Hepatitis C Infections
K. Rajender Reddy – 21 May 2020
Interrelationship Between Coronavirus Infection and Liver Disease
Esperance A. K. Schaefer, Ashwini Arvind, Patricia P. Bloom, Raymond T. Chung – 21 May 2020
Iron Chaperone Poly rC Binding Protein 1 Protects Mouse Liver From Lipid Peroxidation and Steatosis
Olga Protchenko, Ethan Baratz, Shyamalagauri Jadhav, Fengmin Li, Minoo Shakoury‐Elizeh, Oksana Gavrilova, Manik C. Ghosh, James E. Cox, J. Alan Maschek, Vladimir A. Tyurin, Yulia Y. Tyurina, Hülya Bayir, Allegra T. Aron, Christopher J. Chang, Valerian E. Kagan, Caroline C. Philpott – 21 May 2020